Evidence map›Paper›PMID 26890638›Full record

ArticlePloS one2016

T47D Cells Expressing Myeloperoxidase Are Able to Process, Traffic and Store the Mature Protein in Lysosomes: Studies in T47D Cells Reveal a Role for Cys319 in MPO Biosynthesis that Precedes Its Known Role in Inter-Molecular Disulfide Bond Formation.

Richard P Laura, David Dong, Wanda F Reynolds, Richard A Maki

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Biosynthesis of human myeloperoxidase.Archives of biochemistry and biophysics · 2018
    Review
  8. The association ofOncotarget · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Richard P LauraTorrey Pines Pharmaceuticals, Del Mar, California, United States of America.
David DongSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California, United States of America.
Wanda F ReynoldsSanford-Burnham-Prebys Medical Discovery Institute, La Jolla, California, United States of America.
Richard A MakiTorrey Pines Pharmaceuticals, Del Mar, California, United States of America.
Discovery Institute · USTorrey Pines Institute For Molecular Studies · US

Funding

MPO oxidants in synucleinopathiesR01NS074303 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REYNOLDS, WANDA F · 2011 to 2015
$1.9M
MYELOPEROXIDASE INVOLVEMENT IN ALZHEIMER'S DISEASER01AG017879 · NIA · SIDNEY KIMMEL CANCER CENTER · PI REYNOLDS, WANDA F · 2001 to 2005
$1.9M
Regulated Expression of Myeloperoxidase in AtherosclerosisR01HL088428 · NHLBI · SIDNEY KIMMEL CANCER CENTER · PI REYNOLDS, WANDA F · 2008 to 2011
$1.5M
Development of Myeloperoxidase Inhibitors to Treat Alzheimer's DiseaseR43AG040935 · NIA · TORREY PINES PHARMACEUTICALS, INC. · PI MAKI, RICHARD ALLAN · 2012 to 2013
$521k
Development of myeloperoxidase inhibitors to treat atherosclerosisR43HL095251 · NHLBI · TORREY PINES PHARMACEUTICALS, INC. · PI MAKI, RICHARD ALLAN · 2009 to 2009
$274k
NHLBI NIH HHS R01 HL088428NHLBI NIH HHS R43 HL095251NIA NIH HHS R01 AG017879NIA NIH HHS R01-AG017879NIA NIH HHS R01-AG040623NIA NIH HHS R43 AG040935NINDS NIH HHS R01 NS074303NINDS NIH HHS R01-NS074303
6 · The paper itself

Abstract

Among the human heme-peroxidase family, myeloperoxidase (MPO) has a unique disulfide-linked oligomeric structure resulting from multi-step processing of the pro-protein monomer (proMPO) after it exits the endoplasmic reticulum (ER). Related family members undergo some, but not all, of the processing steps involved with formation of mature MPO. Lactoperoxidase has its pro-domain proteolytically removed and is a monomer in its mature form. Eosinophil peroxidase undergoes proteolytic removal of its pro-domain followed by proteolytic separation into heavy and light chains and is a heterodimer. However, only MPO undergoes both these proteolytic modifications and then is further oligomerized into a heterotetramer by a single inter-molecular disulfide bond. The details of how and where the post-ER processing steps of MPO occur are incompletely understood. We report here that T47D breast cancer cells stably transfected with an MPO expression plasmid are able to efficiently replicate all of the processing steps that lead to formation of the mature MPO heterotetramer. MPO also traffics to the lysosome granules of T47D cells where it accumulates, allowing in-depth immunofluorescent microscopy studies of MPO trafficking and storage for the first time. Using this novel cell model we show that formation of MPO's single inter-molecular disulfide bond can occur normally in the absence of the proteolytic events that lead to separation of the MPO heavy and light chains. We further demonstrate that Cys319, which forms MPO's unique inter-molecular disulfide bond, is important for events that precede this step. Mutation of this residue alters the glycosylation and catalytic activity of MPO and blocks its entry into the endocytic pathway where proteolytic processing and disulfide bonding occur. Finally, using the endocytic trafficking of lysosomal hydrolases as a guide, we investigate the role of candidate receptors in the endocytic trafficking of MPO.

Indexed as

Gene ExpressionProtein Processing, Post-TranslationalCathepsinsCell LineCell Line, TumorCystineDisulfidesEndoplasmic ReticulumEnzyme ActivationGene Knockdown TechniquesGlycosylationHumansIntracellular SpaceLysosomesMannosephosphatesMutationCathepsinsCystineDisulfidesmannose-6-phosphateMannosephosphatesPeroxidaseRNA, Small Interfering

Identifiers

PMID26890638
PMCPMC4758715
OpenAlexW2285601991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.